Kana Lessig Stemsoft Software May 2026

Manually tracking these data points—from collection to apheresis, manufacturing, and final infusion—leads to inefficiencies and potential risks. Streamlining Compliance with Configurable Informatics

Based on the available information, there is no direct public link between a person named "Kana Lessig" and STEMSOFT Software. Kana Lessig Stemsoft Software

(e.g., a case study or press release).

Manufacturing and administering advanced therapies requires complete, accurate, and detailed records. Whether you are a cord blood bank, a public marrow transplant center, or a commercial cell therapy manufacturer, the regulatory landscape is constantly evolving, requiring strict adherence to FACT/JACIE, AABB, cGMP, and cGTP standards. a public marrow transplant center

through barcoding, instrument integration, and automation. Moving Beyond Data Collection or a commercial cell therapy manufacturer